DIMENSIONAL FUND ADVISORS LP - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 151 filers reported holding ANIKA THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$18,979,704
-7.7%
749,284
-7.5%
0.01%
-16.7%
Q1 2024$20,567,777
+10.5%
809,755
-1.4%
0.01%
+20.0%
Q4 2023$18,614,101
+16.2%
821,452
-4.5%
0.01%0.0%
Q3 2023$16,024,553
-36.9%
860,135
-12.0%
0.01%
-37.5%
Q2 2023$25,405,034
-9.6%
977,862
-0.0%
0.01%
-11.1%
Q1 2023$28,096,203
+98795.5%
978,300
+1.9%
0.01%
+12.5%
Q4 2022$28,410
-99.9%
959,746
+2.1%
0.01%
-11.1%
Q3 2022$22,367,000
+11.2%
939,802
+4.3%
0.01%
+28.6%
Q2 2022$20,108,000
-8.0%
900,887
+3.5%
0.01%0.0%
Q1 2022$21,853,000
-28.8%
870,299
+1.7%
0.01%
-22.2%
Q4 2021$30,675,000
-16.4%
856,124
-0.7%
0.01%
-25.0%
Q3 2021$36,683,000
-0.7%
861,933
+1.0%
0.01%0.0%
Q2 2021$36,958,000
+5.0%
853,720
-0.8%
0.01%0.0%
Q1 2021$35,186,000
-12.1%
860,554
-2.7%
0.01%
-14.3%
Q4 2020$40,015,000
+22.7%
884,116
-4.1%
0.01%0.0%
Q3 2020$32,613,000
-7.2%
921,580
-1.0%
0.01%
-6.7%
Q2 2020$35,137,000
+29.0%
931,332
-1.2%
0.02%
+7.1%
Q1 2020$27,240,000
-47.5%
942,233
-5.9%
0.01%
-26.3%
Q4 2019$51,917,000
-9.5%
1,001,294
-4.2%
0.02%
-13.6%
Q3 2019$57,359,000
+34.6%
1,044,991
-0.4%
0.02%
+29.4%
Q2 2019$42,622,000
+37.6%
1,049,305
+2.5%
0.02%
+41.7%
Q1 2019$30,971,000
-7.6%
1,024,179
+2.7%
0.01%
-20.0%
Q4 2018$33,523,000
-20.3%
997,441
-0.0%
0.02%
-6.2%
Q3 2018$42,074,000
+34.5%
997,485
+2.0%
0.02%
+33.3%
Q2 2018$31,282,000
-32.4%
977,569
+5.0%
0.01%
-36.8%
Q1 2018$46,278,000
-4.8%
930,771
+3.3%
0.02%
-5.0%
Q4 2017$48,589,000
-6.5%
901,304
+0.6%
0.02%
-13.0%
Q3 2017$51,945,000
+19.9%
895,600
+2.0%
0.02%
+15.0%
Q2 2017$43,321,000
+29.2%
878,006
+13.8%
0.02%
+25.0%
Q1 2017$33,522,000
-6.4%
771,699
+5.5%
0.02%
-11.1%
Q4 2016$35,823,000
+2.6%
731,679
+0.2%
0.02%
-5.3%
Q3 2016$34,926,000
-13.0%
729,924
-2.4%
0.02%
-17.4%
Q2 2016$40,134,000
+14.9%
748,083
-4.2%
0.02%
+9.5%
Q1 2016$34,935,000
+18.1%
781,196
+0.8%
0.02%
+16.7%
Q4 2015$29,575,000
+26.6%
775,025
+5.6%
0.02%
+20.0%
Q3 2015$23,359,000
-1.6%
733,870
+2.1%
0.02%0.0%
Q2 2015$23,750,000
-18.9%
719,061
+1.1%
0.02%
-16.7%
Q1 2015$29,281,000
-10.5%
711,225
-11.4%
0.02%
-14.3%
Q4 2014$32,717,000
-6.0%
803,068
-15.4%
0.02%
-16.0%
Q3 2014$34,789,000
-21.1%
948,932
-0.2%
0.02%
-19.4%
Q2 2014$44,066,000
+15.2%
951,130
+2.2%
0.03%
+6.9%
Q1 2014$38,242,000
+9.3%
930,486
+1.5%
0.03%
+7.4%
Q4 2013$34,980,000
+66.1%
916,678
+4.3%
0.03%
+50.0%
Q3 2013$21,057,000
+47.7%
878,814
+4.8%
0.02%
+38.5%
Q2 2013$14,258,000838,7120.01%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2014
NameSharesValueWeighting ↓
Portolan Capital Management 217,105$10,058,0002.20%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 284,393$13,175,0000.88%
AMI ASSET MANAGEMENT CORP 183,494$8,501,0000.84%
CAPITAL MANAGEMENT CORP /VA 49,765$2,306,0000.74%
TFS CAPITAL LLC 105,839$4,904,0000.39%
Baltimore-Washington Financial Advisors, Inc. 24,390$1,130,0000.35%
OBERWEIS ASSET MANAGEMENT INC/ 27,600$1,279,0000.32%
Stephens Investment Management Group LLC 192,650$8,925,0000.27%
THOMPSON SIEGEL & WALMSLEY LLC 263,622$12,214,0000.24%
DIKER MANAGEMENT LLC 21,200$982,0000.22%
View complete list of ANIKA THERAPEUTICS INC shareholders